Bespoke Extracts, Inc. Announces Uplisting to OTCQB Venture Market
Bespoke Extracts, Inc. (OTC: BSPK) announced its uplisting from the OTC Pink Open Market to the OTCQB Venture Market, effective May 10, 2022. This transition aims to enhance visibility and trading liquidity for retail and institutional investors. Recognized by the SEC, the OTCQB requires ongoing compliance with financial reporting and operational standards. CEO Michael Feinsod highlighted this milestone as a significant step towards transparency and growth, with plans for regular updates to shareholders.
- Successful uplisting to OTCQB, increasing visibility to investors.
- Enhanced trading liquidity anticipated for shareholders.
- Company has a history of losses and needs to raise additional financing.
- Possible risks related to product acceptance in the marketplace.
Denver, CO, May 09, 2022 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTC: BSPK) ("Bespoke" or the "Company"), a company focusing on consumer products in regulated cannabis and CBD is pleased to announce its successful uplisting from the OTC Pink Open Market to the OTCQB Venture Market (the “OTCQB”). Bespoke will commence trading on the OTCQB at the market open on May 10, 2022 under the ticker “BSPK.” The Company believes that the uplist will create greater visibility to retail and institutional investors, as well as further enhance trading liquidity.
The OTCQB is operated by OTC Markets Group Inc. and recognized by the U.S. Securities and Exchange Commission as an established public market. The OTCQB is designed for developing U.S. and international companies, subject to ongoing listing requirements that include remaining current in financial reporting, undergoing an annual verification and management certification process, meeting a minimum bid price, and other specific financial conditions.
“Moving to the OTCQB is the result of our commitment to compliance, quality controls, and complete transparency to our current shareholders and those that will become shareholders of Bespoke in the future,” commented Michael Feinsod, Chief Executive Officer of Bespoke. “This is a significant milestone and a logical progression for the Company as part of our goal to make 2022 a transformational year for Bespoke. We look forward to providing our shareholders regular updates on our progress in the coming weeks and months.”
About Bespoke Extracts, Inc.
Bespoke Extracts, Inc operates with the belief that quality craft cannabis and CBD products should be easily and conveniently accessible. We intend to be a company known for quality, expertise and reliability, producing the highest quality products in the markets where we operate. For more information, please visit https://bespokeextracts.com.
Forward Looking Statements
Matters discussed in this press release contain forward-looking statements. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with our history of losses and our need to raise additional financing, the acceptance of our products in the marketplace, and our need to increase the size of our organization. Further information on the Company's risk factors is contained in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason except as may be required under applicable law.
Investor Contact:
Bespoke Extracts, Inc.
Michael Feinsod
michael@bespokeextracts.com
FAQ
What does the uplisting to OTCQB mean for BSPK shareholders?
When will BSPK start trading on the OTCQB?
What are the compliance requirements for BSPK on the OTCQB?
Who commented on the significance of the uplisting for BSPK?
